Skip to content

Dr. Sofie Ryckx

Active
Private limited companyfounded 2018active for 8 yearsBoonakker 8, 9140 Temse, BelgiumKBO/BCE: BE 0707.739.417

From the official registers: KBO 8 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

Dr. Sofie Ryckx has been active since 2018 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €114,970 and a net result of €95,679. Equity has been growing by about 40% per year since 2018. Its solvency ranks better than 88% of 20,678 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Overview

Official details

KBO
Status
Active since 03-10-2018 Normal situation
Activity
Specialist medical practice NACE 86220and 1 other
Establishment unit
2.280.339.346 9140 Temse, since 03-10-2018
Financial year end
31 December
Peppol
Reachable since 09-08-2024

Board and ownership

Board
  • Ryckx SofieDirector

Financial position

95 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€130,143
▼ 15.3%
Turnover
≈ €240,000
estimated
Profit
€95,679
▼ 16.3%
Equity
€114,970
▼ 56.0%
Total assets
€124,215
▼ 54.9%
Filed on 29-06-2026, 32 days before the deadlineat the National Bank
Score breakdownlowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 2.67, cash €20,405, halvedFigures for financial year 2025 (filed on 29-06-2026)Equity €114,970 (92.6% of total assets)Show the evidence

Checked score

Score 2025
95 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 56% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 100=
equity 92.6% of total assets
Liquidity 71-29
short-term debt 7.4% · cash 16.4%
Profitability 100=
return on assets 77.0%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,155 companies, NACE 86, micro)
Last 24 months 11-2024: < 0.1%lowest value 12-2024: < 0.1%● unchanged vs 11-2024lowest value 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026highest value 08-2026: < 0.1%● unchanged vs 07-2026highest value 09-2026: < 0.1%● unchanged vs 08-2026highest value 10-2026: < 0.1%● unchanged vs 09-2026
Credit of up to €10,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 2.67 (9.53 in 2024), above the usual 1.5. Short-term debt is 7.4% and cash 16.4% of total assets. 7.4% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 82% of them on solvency, 51% on liquidity, 80% on profitability and 11% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 2.67, cash €20,405, halved
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed on 29-06-2026)
NBB · annual accounts
lowers risk · Equity €114,970 (92.6% of total assets)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 29-06-2026, 32 days ahead of the deadline.
NBB · 8 filings
Deviation from the deadline
2025
32 days early
2024
31 days early
2023
36 days early
2022
32 days early
2021
32 days early
2020
32 days early
2019
31 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 32 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 29 June (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
01-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Financials

Financials · financial year 2025, micro format

Annual accounts 2025 filed on 29-06-2026 at the NBB all 8 filings

Turnover
≈ €240,000
Estimated: probably between €210,000 and €320,000
Total assets
€124,215▼ 54.9%
2024 · €275,238
Net result
€95,679▼ 16.3%
2024 · €114,289
Working capital
€15,484▼ 87.0%
2024 · €118,960
Trend over the years

2021 to 2025, 5 financial years 2018 to 2025, 8 financial years

The operating result for 2025 is 17% lower than in 2024.

Operating result€120,704 2025 Net result€95,679 2025

Turnover is what the company sold, the result is what was left of it. A loss stands below the zero line.

Use the arrow keys on the chart for the figures per year.

The sector band is the middle half of the companies in Human health activities (NACE 86). A quarter of them sit below it, a quarter above. Each year counts only accounts in the same format, and only where there are at least 30. The dashed line is the median. There is a sector band for net result, equity, total assets, working capital, solvency, current ratio and return on assets (ROA).

Every figure with its change against the financial year before
favourable unfavourable
Line20182019202020212022202320242025
Operating result-€2,572-€54,772€30,246▼ 44.8%€90,144▲ 198%€79,757▼ 11.5%€82,428▲ 3.3%€146,303▲ 77.5%€120,704▼ 17.5%
Net result-€2,572-€43,947€23,563within the sector's middle half▼ 46.4%€71,142within the sector's middle half▲ 202%€62,555within the sector's middle half▼ 12.1%€64,705within the sector's middle half▲ 3.4%€114,289within the sector's middle half▲ 76.6%€95,679within the sector's middle half▼ 16.3%
Equity€9,828-€53,775▲ 447%€77,338within the sector's middle half▲ 43.8%€83,542within the sector's middle half▲ 8.0%€146,097within the sector's middle half▲ 74.9%€217,002within the sector's middle half▲ 48.5%€261,291within the sector's middle half▲ 20.4%€114,970within the sector's middle half▼ 56.0%
Total assets€20,042-€55,152▲ 175%€79,985below the sector's middle half▲ 45.0%€85,790below the sector's middle half▲ 7.3%€148,381within the sector's middle half▲ 73.0%€226,235within the sector's middle half▲ 52.5%€275,238within the sector's middle half▲ 21.7%€124,215within the sector's middle half▼ 54.9%
Debt€10,214-€1,377▼ 86.5%€2,647▲ 92.2%€2,247▼ 15.1%€2,284▲ 1.6%€9,233▲ 304%€13,946▲ 51.0%€9,244▼ 33.7%
Working capital€5,849-€51,426▲ 779%€75,498within the sector's middle half▲ 46.8%€73,618within the sector's middle half▼ 2.5%€133,925within the sector's middle half▲ 81.9%€128,839within the sector's middle half▼ 3.8%€118,960within the sector's middle half▼ 7.7%€15,484within the sector's middle half▼ 87.0%
Solvency49.0%-97.5%▲ 48.5pp96.7%above the sector's middle half▼ 0.8pp97.4%above the sector's middle half▲ 0.7pp98.5%above the sector's middle half▲ 1.1pp95.9%above the sector's middle half▼ 2.5pp94.9%above the sector's middle half▼ 1.0pp92.6%above the sector's middle half▼ 2.4pp
Current ratio1.57-38.35▲ 36.7729.52above the sector's middle half▼ 8.8233.76above the sector's middle half▲ 4.2359.63above the sector's middle half▲ 25.8714.95above the sector's middle half▼ 44.689.53above the sector's middle half▼ 5.422.67within the sector's middle half▼ 6.85
Return on assets (ROA)-12.8%-79.7%▲ 92.5pp29.5%above the sector's middle half▼ 50.2pp82.9%above the sector's middle half▲ 53.5pp42.2%above the sector's middle half▼ 40.8pp28.6%within the sector's middle half▼ 13.6pp41.5%above the sector's middle half▲ 12.9pp77.0%above the sector's middle half▲ 35.5pp
above within below The sector band is the middle half of the companies in Human health activities (NACE 86). A quarter of them sit below it, a quarter above. Each year counts only accounts in the same format, and only where there are at least 30.
Turnover and EBIT margin are not published. The micro format does not require them. The turnover shown is an estimate from the gross margin.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €124,215
Fixed assets €99,487 ▼ 30.1%
Current assets €24,728 ▼ 81.4%
Equity and liabilities €124,215
Equity €114,970 ▼ 56.0%
Debt €9,244 ▼ 33.7%
Debt's share of the balance-sheet total rises from 5.1% to 7.4%. Equity and debt are lower.
Key figures and ratios
2025 value · change against 2024
EBITDA
€129,171▼
2024 · €152,984
Cash flow
€104,146▼
2024 · €120,971
Debt to equity
0.08▲
2024 · 0.05
ROE
83.2%▲
2024 · 43.7%
Interest coverage
over 100
2024 · over 100
Debt ≤ 1 year
€9,244▼
2024 · €13,946
Income taxes
€26,145▼
2024 · €32,998
Green means a favourable move, even when the figure itself falls, as with debt or debt to equity.

Comparable companies

These companies have the same main activity as Dr. Sofie Ryckx: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €114,000 and €131,000, founded in 2018.

CompanyFoundedTotal assetsEquityGross marginNet resultFinancial year
Dr. Sofie Ryckx Temse2018€124,215€114,970€130,143€95,6792025
Picopsy Lasne2018€125,015€2,660€128,624€95,7982025
Dr. Leen Sinnaeve Oostkamp2018€129,268€19,336€124,990€94,6362025
JANSSENS DERMATOLOGIE Saint-Hubert2018€130,992€20,460€125,855€75,4102025
Dr. Samoy Katrien Leuven2018€118,899€108,460€119,941€90,3352025
Dr. C. HUBERT Urologie Liège2018€130,400€20,405€142,968€102,1612026
Skin Practice Grimbergen2018€114,352€20,415€117,073€84,7282025

They were chosen from the 8,159 other active companies with that main activity and annual accounts from the past two years. All companies with this main activity

Companies with the same profile, two years later

Historical observation

In July 2024, 26,972 companies had the same profile as Dr. Sofie Ryckx has now. Two years later, 1.6% had gone bankrupt and 94.9% were still going.

  • Micro
  • 5 to 10 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
1.6% went bankrupt
3.4% stopped otherwise
94.9% was still going

Another 0.1% stopped without a precise date, possibly only after those two years.

The bankruptcy probability of Dr. Sofie Ryckx itself is lower: < 0.1% within 12 months. It rests on far more data about Dr. Sofie Ryckx than the profile alone.

Test of the method

The method was tested on the 497,445 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 26,972 companies, not a prediction for Dr. Sofie Ryckx. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Subsidies and aid

Flemish government

2023 · 1 entry · €900 awarded · €900 paid
Schemes
1 entry · €900 · €900 paid · Fonds voor Innoveren en Ondernemen
Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 42 lines

Source: Annual accounts 2025 at the NBB, filed on 29-06-2026.

Balance sheet Code20242025
Assets
Total assets20/58€275,238€124,215▼
Fixed assets21/28€142,331€99,487▼
Tangible fixed assets22/27€55,241€47,799▼
Plant, machinery and equipment23€2,265€5,041▲
Furniture and vehicles24€6,627€1,410▼
Other tangible fixed assets26€46,349€41,349▼
Financial fixed assets28€87,091€51,688▼
Current assets29/58€132,907€24,728▼
Cash at bank and in hand54/58€129,704€20,405▼
Deferred charges and accrued income490/1€3,202€4,323▲
Equity and liabilities
Total equity and liabilities10/49€275,238€124,215▼
Equity10/15€261,291€114,970▼
Contributions10/11€18,600€18,600=
Reserves13€242,000€96,000▼
Distributable reserves133€242,000€96,000▼
Profit (loss) carried forward14€691€370▼
Amounts payable17/49€13,946€9,244▼
Amounts payable within one year42/48€13,946€9,244▼
Trade debts44€403€132▼
Suppliers440/4€403€132▼
Taxes, remuneration and social security45€13,543€9,113▼
Taxes450/3€9,000€5,771▼
Remuneration and social security454/9€4,543€3,341▼
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€6,681€8,467▲
Other operating charges640/8€601€973▲
Gross operating margin9900€153,585€130,143▼
Operating profit (loss)9901€146,303€120,704▼
Financial income75/76B€1,333€1,506▲
Recurring financial income75€1,333€1,506▲
Financial charges65/66B€348€385▲
Recurring financial charges65€348€385▲
Profit (loss) for the period before taxes9903€147,288€121,824▼
Income taxes67/77€32,998€26,145▼
Profit (loss) for the period9904€114,289€95,679▼
Profit (loss) for the period to be appropriated9905€114,289€95,679▼
Appropriation of the result
Profit (loss) to be appropriated9906€114,691€96,370▼
Profit (loss) brought forward from the previous period14P€402€691▲
Transfer from equity791/2€70,000€242,000▲
Transfer to equity691/2€114,000€96,000▼
To other reserves6921€114,000€96,000▼
Profit to be distributed694/7€70,000€242,000▲
Return on contributions (dividend)694€70,000€242,000▲

The notes to these accounts have 10 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the accounts filed with the NBB.

Line20182019202020212022202320242025Change
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€1,990€2,169€2,418€1,542€3,452€4,009€6,681€8,467▲ 26.7%
Other operating charges640/8---€1,331€1,171€1,021€601€973▲ 61.7%
Non-recurring operating charges66A---€180-----
Gross operating margin9900-€12€57,864€33,854€93,196€84,380€87,459€153,585€130,143▼ 15.3%
Operating profit (loss)9901-€2,572€54,772€30,246€90,144€79,757€82,428€146,303€120,704▼ 17.5%
Financial income75/76B------€1,333€1,506▲ 12.9%
Recurring financial income75--€1---€1,333€1,506▲ 12.9%
Financial charges65/66B---€72€45€45€348€385▲ 10.6%
Recurring financial charges65-€25€59€72€45€45€348€385▲ 10.6%
Profit (loss) for the period before taxes9903-€2,572€54,747€30,188€90,072€79,712€82,383€147,288€121,824▼ 17.3%
Income taxes67/77-€10,800€6,625€18,929€17,157€17,678€32,998€26,145▼ 20.8%
Profit (loss) for the period9904-€2,572€43,947€23,563€71,142€62,555€64,705€114,289€95,679▼ 16.3%
Profit (loss) for the period to be appropriated9905-€2,572€43,947€23,563€71,142€62,555€64,705€114,289€95,679▼ 16.3%
Line20182019202020212022202320242025Change
Assets
Total assets20/58€20,042€55,152€79,985€85,790€148,381€226,235€275,238€124,215▼ 54.9%
Fixed assets21/28€3,979€2,349€1,840€9,924€12,173€88,164€142,331€99,487▼ 30.1%
Tangible fixed assets22/27€3,979€2,349€1,840€9,924€9,173€25,164€55,241€47,799▼ 13.5%
Plant, machinery and equipment23---€3,980€3,345€1,243€2,265€5,041▲ 123%
Furniture and vehicles24---€5,945€5,828€4,355€6,627€1,410▼ 78.7%
Other tangible fixed assets26-----€19,566€46,349€41,349▼ 10.8%
Financial fixed assets28----€3,000€63,000€87,091€51,688▼ 40.7%
Current assets29/58€16,063€52,803€78,145€75,866€136,209€138,072€132,907€24,728▼ 81.4%
Amounts receivable within one year40/41-€1,700-€11,891€3,170€2,560---
Trade receivables40---€9,741-----
Other amounts receivable41---€2,150€3,170€2,560---
Cash at bank and in hand54/58€15,354€49,980€77,046€61,991€129,188€132,228€129,704€20,405▼ 84.3%
Deferred charges and accrued income490/1---€1,984€3,851€3,284€3,202€4,323▲ 35.0%
Equity and liabilities
Total equity and liabilities10/49€20,042€55,152€79,985€85,790€148,381€226,235€275,238€124,215▼ 54.9%
Equity10/15€9,828€53,775€77,338€83,542€146,097€217,002€261,291€114,970▼ 56.0%
Contributions10/11€12,400€12,400-€12,400€12,400€18,600€18,600€18,600=
Reserves13-€41,000€64,000€70,000€133,000€198,000€242,000€96,000▼ 60.3%
Distributable reserves133---€70,000€133,000€198,000€242,000€96,000▼ 60.3%
Profit (loss) carried forward14-€2,572€375€938€1,142€697€402€691€370▼ 46.5%
Amounts payable17/49€10,214€1,377€2,647€2,247€2,284€9,233€13,946€9,244▼ 33.7%
Amounts payable within one year42/48€10,214€1,377€2,647€2,247€2,284€9,233€13,946€9,244▼ 33.7%
Trade debts44€2,196€1,377€1,347€1,347€1,349€1,350€403€132▼ 67.3%
Suppliers440/4---€1,347€1,349€1,350€403€132▼ 67.3%
Taxes, remuneration and social security45---€900€900€7,883€13,543€9,113▼ 32.7%
Taxes450/3------€9,000€5,771▼ 35.9%
Remuneration and social security454/9---€900€900€7,883€4,543€3,341▼ 26.5%
Other amounts payable47/48----€35----
Line20182019202020212022202320242025Change
Profit (loss) for the period9904-€2,572€43,947€23,563€71,142€62,555€64,705€114,289€95,679▼ 16.3%
+ Depreciation and write-downs630€1,990€2,169€2,418€1,542€3,452€4,009€6,681€8,467▲ 26.7%
Operating cash flow (approximation)-€582€46,116€25,981€72,684€66,007€68,714€120,971€104,146▼ 13.9%
Investment in fixed assets (approximation)--€539-€1,909-€9,626-€5,700-€80,000-€60,849€34,378-
Change in cash-€34,626€27,066-€15,055€67,197€3,040-€2,524-€109,299▼ 4,231%

A Belgian filing has no cash-flow statement. These rows are therefore an approximation, derived from the income statement and the balance-sheet moves.

Download as CSV

Filings with the National Bank (8)
Financial year Type Filed Reference Document
31-12-2025 micro format 29-06-2026 2026-00210115 NBB
31-12-2024 micro format 30-06-2025 2025-00202138 PDF
31-12-2023 micro format 25-06-2024 2024-00157366 PDF
31-12-2022 micro format 29-06-2023 2023-00171299 PDF
31-12-2021 micro format 29-06-2022 2022-20104162 PDF
31-12-2020 micro format 29-06-2021 2021-25900407 PDF
31-12-2019 micro format 30-06-2020 2020-22400537 PDF
31-12-2018 micro format 28-06-2019 2019-23900124 PDF

Board & ownership

Directors

Directors
1 director
Ryckx Sofie
Director · listed in the 2025 annual accounts, filed on 29-06-2026
Current

Owners and capital

Shareholders

  • RYCKX Sofie €6,200 in cash

Network & group

Dr. Sofie Ryckx shares no director with another company.

Connections & network

1 current director
Depth

The network starts from the directors of Dr. Sofie Ryckx. Every other company they run is a node.

This company Company Director Shareholding +N: links not shown yet Click a node to look further, drag to arrange, zoom with the mouse wheel.

Timeline

Acts, filings and financial milestones

Deadline for the 2026 accounts: 31-07-2027
2026
29-06
NBB filing Annual accounts filedNBB
financial year 2025 · micro format
2025
30-06
NBB filing Annual accounts filedPDF
financial year 2024 · micro format
2024
31-12
Financial Highest result from 2018 to 2025net €114,289 ▲76.6%
The operating result of €146,303 and the net result of €114,289 are both a record.
25-06
NBB filing Annual accounts filedPDF
financial year 2023 · micro format
2023
31-12
Financial Equity above €200,000equity €217,002 ▲48.5%
After 5 profitable years in a row, equity reaches €217,002.
29-06
NBB filing Annual accounts filedPDF
financial year 2022 · micro format
2022
31-12
Financial Equity above €100,000equity €146,097 ▲74.9%
After 4 profitable years in a row, equity reaches €146,097.
29-06
NBB filing Annual accounts filedPDF
financial year 2021 · micro format
03-06
Gazette deed Miscellaneous
Capital contribution · Power of attorney4 points ▸
  • General meeting, 19-05-2022
  • Capital contribution, €6,200, mentioned 2 times in the deed
  • Other provision, “vaststelling bijkomende inbreng en stand beschikbare eigenvermogensrekening”, 6200 (deed in Dutch)
  • Power of attorney

Open the act in the Belgian Official Gazette

2021
29-06
NBB filing Annual accounts filedPDF
financial year 2020 · micro format
2020
30-06
NBB filing Annual accounts filedPDF
financial year 2019 · micro format
2019
31-12
Financial Back to profitnet €43,947
The net result is €43,947, after one loss-making year.
31-12
Financial Liquidity more than 24 timescurrent ratio 38.35
The current ratio rises from 1.57 to 38.35. Short-term debt falls from €10,214 to €1,377.
28-06
NBB filing Annual accounts filedPDF
financial year 2018 · micro format
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.

Sources:Publications in the Belgian Official GazetteFilings with the National Bank

History

Dr. Sofie Ryckx was incorporated on 3 October 2018.1 Total assets rose from €20,042 in 2018 to €124,215 in 2025.2

  1. 1KBO register
  2. 2National Bank, annual accounts 2018 and 2025

Company details

Register details

Identity

KBO record
Name Dr. Sofie Ryckx in Dutch
Enterprise number 0707.739.417
Legal form Private limited company
Status Active, normale toestand
Founded 03-10-2018
Entity type Legal entity

Registered office and establishments

Registered office Boonakker 8, 9140 Temse, Belgium
Establishments 1 establishment unit since 2018

Activities

NACEBEL 2025
86220 Specialist medical practice main activity
86210 General medical practice

Invoicing and payment

VAT number BE 0707.739.417
E-invoicing via Peppol
Reachable via Peppol
Peppol ID 0208:0707739417
Other Peppol ID 9925:BE0707739417
Registered 09-08-2024

Follow this company and you will hear the next morning if it leaves the Peppol register.

Register as of 1 November 2026 · Peppol Directory

Financial year and general meeting

Accounts at the NBB
Financial year end 31-12

Sites & property

Location
registered office establishment The establishment unit on the map
2 companies at this address See who is registered here
1 establishment unit
Dr. Sofie Ryckx
Boonakker 8, 9140 TemseSpecialist medical practice
since 2018unit number 2.280.339.346

Buildings and parcels at the address

Ground area
502 m²
Building footprint
153 m²
Building volume
878 m³
Parcel 46025B0782/00R000, Flanders · tallest building 9.8 m.
1 parcel
Flanders 1 (100%)
Cadastral parcel Region Area Buildings Height / floors
46025B0782/00R000 Flanders 502 m² 1 · 152 m² 9.8 m · 2